This story was originally published by the WND News Center.
Joe Biden, while he was campaigning to be president, repeatedly promoted the leftist, and unscientific, ideology that boys or men can become girls or women.
Being male or female actually is embedded in the body to the DNA level, so that cannot change.
However, Biden became cheerleader for the ideology that has proven lucrative for providers of chemicals and surgeries, and took that promotion to White House heights while in office.
But he ignored, even while promoting those chemicals and those body-mutilating surgeries as "health care," the results now confirmed in a government study that was being developed at the time, and now is released, revealing that all of those attempts to "change" adults didn't "improve their lives."
The agenda immediately was applied to children, despite the failure in "treating" adults.
In fact, according to a report in the Washington Stand, the report, "Treatment for Pediatric Gender Dysphoria: Review of Evidence and Best Practices," released by the Department of Health and Human Services on May 1, said those "same medical interventions had failed to improve the lives of adults."
"Even after full surgery, "improvement' in their actual life situation is not always observed,' noted a transgender psychologist," the report explained.
The patients' "subjective" feelings varied, with some claiming improvement.
But the report highlights the "weak basis and failed results of medical transitions for minors."
To the question, "Did medical transition at least alleviate gender dysphoria?" the response was, "Interestingly, there was no relationship between reported happiness and stage of transition."
So, the "unsuccessful model for adults in time became the basis for the 'affirming model' for minors," the report said.
The Washington Stand noted that Harry Benjamin, the "father of the transgender medicine," once sued the Journal of the American Medical Association for calling his work "quackery," and lost.
Indeed the report explains that while Benjamin promised to change bodies to "at least resemble those of the sex to which they feel they belong," there are few early instances of those surgical procedures and the first known patient, Einar Wegener, who became Lili Elbe, died in 1931 after an "abyss of suffering."
The agenda moved into the U.S. when in 1952 a former soldier traveled to Denmark for surgery and the media screamed, "EX-GI BECOMES BLONDE BEAUTY: OPERATIONS TRANSFORM BRONX YOUTH." He subsequently was met on his return by 300 reporters and was paid $20,000 for an interview.
Still the agenda remained relatively obscure.
Eventually assessments began with a survey of 229 patients in the Netherlands Gender Care Foundation, and, HHS said, "While the self-reported subjective outcomes were good, objective measures told a different story."
"One in seven [male-to-female transitioners] and one in 36 [female-to-male transitioners] had attempted suicide after treatment began. (Of the total number of patients seen at the NGCF in the previous 10 years, three had committed suicide after treatment.) 60% of the MFs and 37% of the FMs were unemployed and 59% of the MFs and 33% of the FMs had no romantic partners," HHS observed.
"If it is possible to discern a trend in these reports that the subjective well-being of the transsexuals has increased, whereas an 'improvement' in their actual life situation is not always observed," the study said, concluding that surgeries did not appear to lessen patients' gender dysphoria.
"Although a fair number of persons attribute their feelings of happiness to SRS, there appears to be no direct relation between the subjective well-being and the phase of therapy. Those who have completed SRS are not happier or less happy than those who are still in the initial phase of therapy. In other words, a person's positive evaluation of his/her life-in-its-totality is not directly related to his/her progress in physical adjustment to the opposite sex."
The conclusion noted pursuing gender alterations is no assurance of happiness and that actually "can lead to new problems."
Despite the facts, the gender industry developed a model of puberty blockers at 12, cross-sex hormones at 16 and surgery at 18.
The results align with multiple other studies that show a high level of suicide, or attempted suicide, among members of the transgender community.
